Protara Therapeutics (TARA) Preferred Shares (2017 - 2020)

Protara Therapeutics' Preferred Shares history runs 4 years deep, the most recent figure standing at $8.0 for Q3 2020.

• In Q3 2020, Preferred Shares fell 100.0% year-over-year to $8.0; the TTM figure through Sep 2020 stood at $8.0 (down 100.0% YoY), while the FY2019 annual figure was $18.5 million, down 14.22% from the prior year.
• Preferred Shares was $8.0 for Q3 2020 at Protara Therapeutics, up from $4.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $21.5 million in Q4 2017 to a low of $4.0 in Q1 2020.
• Historically, Preferred Shares has averaged $14.7 million across 4 years, with a median of $21.2 million in 2019.
• The sharpest annual moves came in 2018 and 2020: Preferred Shares changed 0.0% in 2018, then plunged 100.0% in 2020.
• A 4-year view of Preferred Shares shows it stood at $21.5 million in 2017, then changed by 0.0% to $21.5 million in 2018, then decreased by 14.22% to $18.5 million in 2019, then sank by 100.0% to $8.0 in 2020.
• The last three Preferred Shares figures came in at $8.0 (Q3 2020), $4.0 (Q2 2020), and $4.0 (Q1 2020), per Business Quant data.